Cargando…

Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients

BACKGROUND: The 2019 Coronavirus (COVID-19) pandemic poses a huge threat internationally; however, the role of the host immune system in the pathogenesis of COVID-19 is not well understood. METHODS: Cytokine and chemokine levels and characterisation of immune cell subsets from 20 COVID-19 cases afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qigao, Yu, Baodan, Yang, Yihao, Huang, Jiewen, Liang, Ying, Zhou, Jing, Li, Lianzhong, Peng, Xuechun, Cheng, Bolin, Lin, Yongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052478/ https://www.ncbi.nlm.nih.gov/pubmed/33951560 http://dx.doi.org/10.1016/j.intimp.2021.107685

Ejemplares similares

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
por: Sturek, Jeffrey M., et al.
Publicado: (2022)

What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021)

Immunological Endotyping of Chronic Critical Illness After Severe Sepsis
por: Fenner, Brittany P., et al.
Publicado: (2021)

COVID-19 convalescent plasma composition and immunological effects in severe patients
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2021)

Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)

Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases
por: van Zanten, Arthur Raymond Hubert, et al.
Publicado: (2019)

Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Zhang, Bin, et al.
Publicado: (2020)

Immunological and inflammatory profiles in mild and severe cases of COVID-19
por: Song, Jin-Wen, et al.
Publicado: (2020)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
por: Tirnea, Livius, et al.
Publicado: (2021)

Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Cho, YunSuk, et al.
Publicado: (2021)

Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
por: Semedi, Bambang Pujo, et al.
Publicado: (2022)

Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results
por: de Oliveira, Fernando Anselmo, et al.
Publicado: (2021)

CONVALESCENT PLASMA THERAPY IN CRITICALLY ILL PATIENTS WITH LATE STAGE COVID-19
por: Kumar, Neil, et al.
Publicado: (2020)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
por: Kurtz, Pedro, et al.
Publicado: (2021)

Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients
por: Astola Hidalgo, I., et al.
Publicado: (2023)

Immunological effects of CWHD in critically ill patients
por: Kehler, D, et al.
Publicado: (1998)

Severity of electrophysiological alterations correlates with severity of illness in the early phase of critical illness polyneuropathy
por: Nemes, R, et al.
Publicado: (2012)

Clinical and immunological characteristics in COVID-19 convalescent patients
por: Su, Zhiying, et al.
Publicado: (2021)

Brain rhythmic abnormalities in convalescent patients with anti-NMDA receptor encephalitis: a resting-state EEG study
por: Wu, Dengchang, et al.
Publicado: (2023)

Energy expenditure and indirect calorimetry in critical illness and convalescence: current evidence and practical considerations
por: Moonen, Hanneke Pierre Franciscus Xaverius, et al.
Publicado: (2021)

Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
por: Khamis, Faryal, et al.
Publicado: (2021)

Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis
por: Wenjing, Luo, et al.
Publicado: (2020)

Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
por: Chancellor, John R., et al.
Publicado: (2016)

Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID‐19
por: Donzelli, Massimo, et al.
Publicado: (2020)

Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
por: Khan, Tehmina Nafees Sonia, et al.
Publicado: (2021)

Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients
por: Agrawal, Akanksha, et al.
Publicado: (2022)

Immunomodulation Effect of Convalescent Plasma Therapy in Severe – Critical COVID-19 Patients
por: Fitriah, Munawaroh, et al.
Publicado: (2023)

Post-COVID syndrome: Turning convalescence into illness?
por: Cozzi, Giorgio, et al.
Publicado: (2021)

Convalescence via critical care collaboration
por: Shute, C, et al.
Publicado: (2014)

Immunological Subpopulations Within Critically Ill COVID-19 Patients
por: Wilson, Julie Kay, et al.
Publicado: (2021)

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19
por: Raychaudhuri, Deblina, et al.
Publicado: (2022)

Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
por: Esmaeili, Behnaz, et al.
Publicado: (2021)

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020)

Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review
por: Richard, Seidu A., et al.
Publicado: (2020)

A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19
por: Lung, Thomas, et al.
Publicado: (2020)

The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
por: Toft, Palle, et al.
Publicado: (1999)

Convalescent plasma may not be an effective treatment for severe and critically ill covid-19 patients: A Systematic Review & Meta-Analysis of Randomized Controlled Trials
por: Yang, Penglei, et al.
Publicado: (2022)

Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome
por: Augustin, Max, et al.
Publicado: (2023)

Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4kgpvqufac46g2qvtiib1u68hq